Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$254,392
-$2,323,959 QoQ
Shares Held
4,415
-89.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,981
of 2,506 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Faithward Advisors, LLC holds $6,902,856 across 7 Drug Manufacturers - General names. BMY ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,824 | $1,987,061 | |
| 2 | ABBV |
AbbVie Inc.
|
6,192 | $1,558,154 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,353 | $1,201,860 | |
| 4 | LLY |
ELI LILLY & Co
|
862 | $1,033,908 | |
| 5 | AMGN |
Amgen Inc
|
1,269 | $459,530 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,229 | $407,951 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
4,415 | $254,392 |
All Filings in BMY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $254,392 | 4,415 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,578,351 | 42,512 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $260,206 | 4,824 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $216,885 | 4,809 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $248,206 | 5,362 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $296,106 | 4,855 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $254,859 | 4,506 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $248,817 | 4,809 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $265,401 | 4,894 | Shares | Sole | 2024-05-15 | |
| 2023-03-31 | $303,092 | 4,373 | Shares | Sole | 2023-05-15 | |
| 2020-03-31 | $242,357 | 4,348 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||